XLRN
Acceleron Pharma Inc
A maker of protein drugs for rare blood and lung diseases, Acceleron Pharma developed Reblozyl, an anemia treatment, and sotatercept for a form of pulmonary hypertension, from its base in Cambridge, Massachusetts. It was founded in 2003 under the name Phoenix Pharma before rebranding as Acceleron—a nod to "accelerate." Merck & Co. bought the company in 2021.
CUSIP: 00434H108HealthcareUS1 holder
Total Value
$24.61M
Total Shares
196.1K
Net Share Change
+196.1K
Activity
1 buying
Investor
Value
Shares
Weight
Change
